
1 

(1) This Order may be cited as the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment Order 1994 and shall come into force on 12th October 1994.
(2) In this Order, “the principal Order” means the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Order 1984.
(3) In this Order, a reference to inserting an entry in a column in a Table of a Schedule to the principal Order shall be construed, in the case of an entry to be inserted in column 1, as a reference to inserting that entry at the appropriate point in the alphabetical order of the entries in column 1 of that Table and (except where the context otherwise requires), in the case of an entry to be inserted (as the case may be) in column 2, 3 or 4 of that Table, as a reference to inserting that entry so as to appear against the column 1 entry against which it is listed in Schedule 1, or, as the case may be, Schedule 2 to this Order.
2 
In article 1(2) of the principal Order (interpretation), after the definition of “dosage unit” there is inserted the following definition—“
 “effervescent”, in relation to a tablet, means containing not less than 75 per cent., by weight of the tablet, of ingredients included wholly or mainly for the purpose of releasing carbon dioxide when the tablet is dissolved or dispersed in water;”.
3 

(1) Schedule 1 to the principal Order (which specifies the class of medicinal products, other than products the subject of a product licence of right, on general sale by virtue of article 2(a) of that Order) is amended in accordance with the following provisions of this article.
(2) In Table A (internal or external use)—
(a) there are inserted in column 1 and, as the case may be, columns 2, 3 and 4, those entries set out in columns 1, 2, 3 and 4 respectively of Schedule 1 to this Order;
(b) in relation to the substance “Aspirin”—
(i) there is inserted in column 2 the entry “(3) 500 mg”,
(ii) there is substituted, for the entry “(1) Tablet or capsule” in column 3, the entry “(1) Tablet (except effervescent tablet) or capsule” and
(iii) there is inserted in column 3 the entry “(3) Effervescent tablets”;
(c) there are omitted the entry “Capsicum Oleoresin” in column 1 and the entries in relation to it in columns 2, 3 and 4;
(d) in relation to the substance “Chlorbutol”—
(i) there is inserted in column 2 the entry “(4) 7.0 per cent.”,
(ii) there is substituted, for the entry “(3) External” in column 3, the entry “(3) External (except toothache gel)”, and
(iii) there is inserted in column 3 the entry “(4) External: toothache gel”;
(e) for the entry “Cranesbill Root” in column 1, there is substituted the entry “Cranesbill (Geranium)”;
(f) for the entry “Dandelion Root” in column 1, there is substituted the entry “Dandelion”;
(g) in relation to the substance “Ferrous Sulphate”, there is inserted in column 2 the entry“
(2) 15.8 per cent. (Fe SO4 7H2O)”, and in column 3 the entries“
(1) Internal: except for use as cyanide antidote
(2) Internal: for use as cyanide antidote only”,and for the entry in column 4 there is substituted the entry“
(1) Equivalent to 24 mg elemental Iron (MD)”;
(h) in relation to the substance “Nicotinamide”, there is inserted in column 4 the entry “300 mg (MDD)”;
(i) in relation to the substance “Nicotinic Acid”, there is inserted in column 4 the entry “100 mg (MDD)”;
(j) in relation to the substance “Salicylic Acid”, there is inserted in column 2 at the end the entry “(h) 3.0 per cent.” and there are inserted in column 3 at the end the entries “(h) soap” and “(i) wart plasters”;
(k) in relation to the substance “Zinc Oxide”, for the entry in column 4 there is substituted the entry “Equivalent to 5 mg elemental Zinc (MDD)”; and
(l) in relation to the substance “Zinc Sulphate”, for the entry in column 4 there is substituted the entry “(1) Equivalent to 5 mg elemental Zinc (MDD)”.
(3) In Table B (external use only)—
(a) there are inserted in column 1 and, as the case may be, columns 2 and 3, those entries set out in columns 1, 2 and 3 respectively of Schedule 2 to this Order;
(b) there are omitted the entries “Hamamelis” and “Siberian Fir Oil” in column 1;
(c) there are omitted the entry “Lignocaine” in column 1 and the entry “0.6 per cent” in relation to it in column 2;
(d) there are omitted the entry “Lignocaine Hydrochloride” in column 1 and the entry “0.7 per cent” in relation to it in column 2;
(e) in relation to the substance “Povidone-Iodine”, for the entry in column 3 there is substituted the entry “All preparations except those for use in surgical operations and those for vaginal use”.
Signed by authority of the Secretary of State for Health
Tom Sackville
Parliamentary Under Secretary of State,
Department of Health
16th September 1994John Redwood
Secretary of State for Wales
6th September 1994Allan Stewart
Parliamentary Under Secretary of State, The Scottish Office
6th September 1994Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland on
F. A. Elliott
Permanent Secretary
7th September 1994.
SCHEDULE 1
Article 3(2)(a)


Column 1 Column 2 Column 3 Column 4
Substance Maximum strength Use, pharmaceutical form or route of administration Maximum dose and maximum daily dose
Acerola
Agnus castus (Chaste Tree)
Air
Alexitol Sodium
Alpha Tocopheryl Acid Succinate
Aluminium Carbonate (Basic)
Aluminium Oxide
Aminoacetic Acid (Glycine)
Aminobenzoic Acid  
(1) Internal
(2) External (1) 30mg (MDD)
Ammonium Acetate Solution Strong
Amyloglycosidase Concentrate
Anethole
Aniseed (Anise)
Arrowroot
Balm of Gilead
Bayberry
Betacarotene   6 mg (MDD)
Bismuth Aluminate   6 mg (MD), calculated as Bismuth Oxide
Black Catechu
Black Haw
Blackberry
Black Currant
Bladderwrack (Fucus)
Blue Cohosh (Caulophyllum)   265 mg (MD)
Boneset (Eupatorium perfoliatum)
Buckthorn
Butternut (White Walnut)
Calamus (Sweet Flag)
Calcium Chloride
Calcium Heptagluconate
Calcium Phosphate
Calumba
Capsicum Oleoresin BPC 1923
Capsicum Oleoresin BPC 1973  (1) Internal (1) 1.2mg (MD)
   (1) 1.8mg (MDD)
 (2) 2.5 per cent. (2) External
Caraway Oil
Centaury
Chickweed
Chlorophenols 
(1) 1 mg
(2) 0.6 per cent. 
(1) Internal
(2) External
Cinnamic Acid (1) 500 mcg 
(1) Internal: pastilles, lozenges, throat tablets
(2) External
Clove
Clover (Red Clover)
Cobalt Sulphate   Equivalent to 0.25 mg elemental Cobalt (MDD)
Coriander
Dexpanthenol (Panthenol, Pantothenol)
Docosahexaenoic Acid (DHA)
Domiphen Bromide
Eicosapentaenoic Acid (EPA)
Euphorbia hirta (Euphorbia pilulifera, Pill-Bearing Spurge)
Fast Green FCF
Fennel Oil
Fenugreek
Ferric Chloride   Equivalent to 24 mg elemental iron (MD)
Fibre, Vegetable
Fig
Fir Oil, Siberian
Frangulin
Fringe Tree
Fumitory   160 mg (MD)
Ginseng
Glutamic Acid Hydrochloride
Glycerophosphoric Acid
Gravel Root (Eupatorium purpureum)
Hamamelis
Heartsease
Hemlock Spruce (Pine Canadian)   400 mg (MD)
Horseradish
Hydrangea
Iceland Moss
Inositol
Iodophenol 
(1) 0.2 mg
(2) 0.08 per cent. 
(1) Internal: pastilles, lozenges, throat tablets
(2) External
Kaolin Heavy
Kava   625 mg (MD)
Kelp
Lady’s Mantle
Lemon
Lignocaine 
(1) 0.6 per cent.
(2) 0.6 per cent. 
(1) Internal: teething gel
(2) External, except local ophthalmic use
Lignocaine Hydrochloride 
(1) 0.7 per cent.
(2) 0.7 per cent. 
(1) Internal: teething gel
(2) External, except local ophthalmic use
Liquorice Extract Deglycyrrhizinised
Lucerne (Alfalfa)
Lungwort
Magnesium Stearate
Maize
Malted Milk
Maltose
Manganese Glycerophosphate   Equivalent to 1 mg elemental Manganese (MDD)
Marshmallow Root
Methionine, DL
Motherwort
Myrrh
Nutmeg
Oak Bark
Orange
Pantothenic Acid
Papain
Parsley
Pellitory
Pilewort
Pleurisy Root
Poke Root (Phytolacca)  
(1) Internal
(2) External (1) 120 mg (MD)
Poplar (Aspen)
Potassium Acid Tartrate
Potassium Bicarbonate
Potassium Carbonate
Potassium Citrate
Potassium Molybdate   Equivalent to 200 mcg elemental molybdenum (MDD)
Psyllium
Queen’s Delight   320 mg (MD)
Raspberry
Rosemary
Rubellin
Rutin
Saw Palmetto
Shepherd’s Purse
Skunk Cabbage (Symplocarpus)
Sodium Sulphate
Sodium Acid Phosphate
Sodium Glycerophosphate
Sodium Phosphate
Squaw Vine
Squill, Indian
Stone Root
Tilia (Lime Flowers)
Unicorn Root False
Uva Ursi (Bearberry)
Wahoo (Euonymus atropurpureus)
Watercress
Wheat
Wild Indigo
Wood Betony
Xanthan Gum
Yellow Dock
Zinc Gluconate   Equivalent to 5 mg elemental zinc (MDD)
SCHEDULE 2
Article 3(3)(a)


Column 1 Column 2 Column 3
Substance Maximum Strength Use, Pharmaceutical Form or Route of Administration
Aldioxa (Aluminium Dihydroxyallantoinate)
Allantoin
Aminacrine Hydrochloride
Arnica
Bay Oil
Borax (Sodium Borate) 
(1) 5.0 per cent.
(2) 0.7 per cent. 
(1) All preparations except ophthalmic lotions
(2) Ophthalmic lotions
Boric Acid 2.5 per cent.
Bryony, Black
Burgundy Pitch
Calcium Undecylenate
Calendula (Marigold)
Cedar Wood Oil
Colophony
Comfrey Root
Crotamiton
Dichlorotetrafluroethane
Emulsifying Wax
European Birch
Geranium Oil
Guaiacol
Halquinol 0.6 per cent.
Heparin
Hexetidine 0.1 per cent.
Hexyl Nicotinate 2.0 per cent.
Horse-chestnut (Aesculus)
Hypericum (St. John’s Wort)
Hypophosphorous Acid
Isopentane
Labrador Tea
Lactic Acid
Light Liquid Paraffin
Linseed Oil
Mastic
Melaleuca Oil
Methoxymethane
Mexenone
Microcrystalline Wax
Oleyl Alcohol
Paeony (Peony)
Polyethoxyethanol
Potassium Chloride
Potassium Hydroxide
Potassium Thiocyanate
Propylene Glycol
Pyrethrum (Chrysanthemum)
Rue 0.1 per cent.
Shark Liver Oil 
(1) 3.0 g 
(1) Suppositories
(2) All preparations for external use except suppositories
Sodium Acid Pyrophosphate
Sodium Pyrophosphate
Southern Wood
Talc
Tar
Terebene (Terepene)
Thurfyl Salicylate
Titanium Peroxide
Titanium Salicylate
Wool Alcohols, Acetylated
Zinc Oleate